Skip to content Skip to primary navigation
News

mk2 Bio­tech­no­lo­gies, WACK­ER and TUM jointly devel­op a pro­cess for the large-scale pro­duc­tion of anti­mi­cro­bi­al pep­tides based on sus­tain­able fermentation